The future trends in the APIs production

The future trends in the APIs production

“Traditionally, the pharma industry used to separate the two business models, but I believe there is a case for inn...
The making of APIs

The making of APIs

Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs) in our network of facilities allows clients full access to integrated services resulting in faster production and delivery timelines, with one of the most extensive track records.
Meet the Champions

“Meet the Champions” roundtable

Today ItalyPost Think Tank and Corriere Della Sera Economia promote a roundtable among Presidents of Italian Companies that are driving our economic and social growth, giving a key contribution to employment and development.
Olon receives DWF International Award

Olon receives DWF International Award

Olon Group has been awarded for the performance achieved in 2020, with a prestigious prize received by The British Chamber of Commerce during the latest BCCI Business Excellence Awards.

Future Events

In the coming months we will be present at these sector events. The list is constantly updated and may be subject to changes.


Regulatory inspections

Our facilities are regularly inspected by the most important national and foreign medicine agencies: FDA - Food and Drug Administration (USA), AIFA - Agenzia Italiana del Farmaco (Italy), AEMPS - Agencia Espanola de Medicamentos y productos sanitarios (Spain), Russian Health Authority, PEBC - Pharmacy Examining Board of Canada, COFEPRIS - Comisión Federal para la Protección contra Riesgos Sanitarios (Mexico), TGA - Therapeutic Goods Administration (Australia), PDMA - Pharmaceuticals and Medical Devices Agency (Japan), KFDA - Ministry of Food and Drug Safety (Korea), ANVISA - Agency Nacional de Vigilancia Sanitária (Brazil), WHO - World Health Organization.

2020Derivados Quimicos
2019Ricerca Bioscience